PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Altmann, M. ; Pich, D. ; Ruiss, R. ; Wang, J.* ; Sugden, B.* ; Hammerschmidt, W.

Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes.

Proc. Natl. Acad. Sci. U.S.A. 103, 14188-14193 (2006)
Verlagsversion Volltext DOI PMC
Open Access Gold
EBV is a paradigm for human tumor viruses because, although it infects most people benignly, it also can cause a variety of cancers. Both in vivo and in vitro, EBV infects B lymphocytes in G0, induces them to become blasts, and can maintain their proliferation in cell culture or in vivo as tumors. How EBV succeeds in these contrasting cellular environments in expressing its genes that control the host has not been explained. We have genetically dissected the EBV nuclear antigen 1 (EBNA1) gene that is required for replication of the viral genome, to elucidate its possible role in the transcription of viral genes. Strikingly, EBNA1 is essential to drive transcription of EBV's transforming genes after infection of primary B lymphocytes.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
10.231
0.000
104
108
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter transcription; regulation; high-mobility group A protein; HMGA1a; EPSTEIN-BARR-VIRUS; LYMPHOBLASTOID CELL-LINES; LATENT MEMBRANE-PROTEIN-1; DNA-REPLICATION; INITIAL-STAGES; C-PROMOTER; B-CELLS; INFECTION; EBNA-1; ORIP
Sprache englisch
Veröffentlichungsjahr 2006
HGF-Berichtsjahr 2006
ISSN (print) / ISBN 0027-8424
e-ISSN 1091-6490
Zeitschrift Proceedings of the National Academy of Sciences of the United States of America
Quellenangaben Band: 103, Heft: 38, Seiten: 14188-14193 Artikelnummer: , Supplement: ,
Verlag National Academy of Sciences
Begutachtungsstatus Peer reviewed
Institut(e) Research Unit Gene Vector (AGV)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-501500-001
PubMed ID 16966603
DOI 10.1073/pnas.0605985103
WOS ID 000240746600051
Scopus ID 33749039167
Erfassungsdatum 2006-11-06
[➜Korrektur melden]